Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation
AssigneeChildren's Medical Center Corporation
InventorsYi Zhang, Shogo Matoba
Life of this patent
Estimating the term…
Loading patent…
AssigneeChildren's Medical Center Corporation
InventorsYi Zhang, Shogo Matoba
Estimating the term…
The present invention provides methods and compostions to improve the efficiency of somatic cell nuclear transfer (SCNT) and the consequent production of nuclear transfer ESC (ntESC) and transgenic cells and/or non-human animals. More specifically, the present invention relates to the discovery that trimethylation of Histone H3-Lysine 9 (H3K9me3) in reprogramming resistant regions (RRRs) in the nuclear genetic material of donor somatic cells prevents efficient somatic cell nuclear reprogramming or SCNT. The present invention provide methods and compositions to decrease H3K9me3 in methods to improve efficacy of SCNT by exogenous or overexpression of the demethylase Kdm4 family and/or inhibiting methylation of H3K9me3 by inhibiting the histone methyltransferases Suv39h1 and/or Suv39h2.
A culture medium comprising a population of mammalian somatic cell nuclear transfer (SCNT) embryo-derived embryonic stem cells (ntESCs) isolated in vitro or ex vivo from an inner cell mass of a mammalian SCNT embryo comprising or expressing an exogenous agent that decreases H3K9me3 methylation in the mammalian SCNT embryo, wherein one or both of the ntESCs and the SCNT embryo are genetically modified, wherein the ntESCs in the culture medium are pluripotent or totipotent ntESCs and are maintained in the culture medium in a pluripotent or totipotent undifferentiated state;
Dependencies are inferred from the claim text.